Oct 2026· ACS Applied Materials and Interfaces· Vol 18, pp. 56995-57014· 0 citations· 179 references
Medicine
TL;DR
This work highlights membrane engineering-enabled biological regulation of nanomaterials, offering rational guidelines for the design and scalable fabrication of next-generation biomimetic nanotherapeutics.
Abstract
Cell membrane-coated nanoparticles (CMNPs) have emerged as versatile biomimetic nanoplatforms that inherit native membrane biofunctions, such as immune evasion, specific molecular recognition, and prolonged systemic circulation. Nevertheless, conventional CMNPs suffer from low surface ligand density and weak microenvironment responsiveness, leading to unsatisfactory functional homogeneity and restricted translational applicability. These limitations directly translate into key clinical challenges, including poor active targeting capability, rapid in vivo clearance, and insufficient tumor penetration. To tackle these material engineering limitations, engineered (ECMNPs) have been developed through modular membrane engineering to enable precise and programmable surface functionalization. This review systematically summarizes five mainstream membrane modification strategies for ECMNP construction, including stimuli-responsive functionalization, genetic engineering, covalent conjugation, noncovalent assembly, and membrane fusion. By integrating endogenous membrane bioactivity with artificially optimized nanostructures, ECMNPs exhibit tunable targeting capability, stimuli-triggered drug release, immunomodulatory effects, and enhanced transbarrier delivery for treating intractable diseases. We further discuss key translational bottlenecks regarding membrane sourcing, extraction procedures, structural stability, and biological safety. This work highlights membrane engineering-enabled biological regulation of nanomaterials, offering rational guidelines for the design and scalable fabrication of next-generation biomimetic nanotherapeutics.
Biomimetic cell membrane-coated nanoparticles (CM-NPs) have emerged as a promising class of nanocarriers that integrate the tunable physicochemical properties of engineered nanoparticles with selected biological features of naturally derived cell membranes. By retaining membrane-associated proteins, lipids, glycans, an...
Covalent organic frameworks (COFs) have attracted growing interest as drug delivery platforms owing to their ordered porosity, tunable pore architecture, and versatile chemical functionality. Favorable physicochemical characteristics alone, however, do not guarantee effective performance in vivo, and biomimetic membran...
Hina Ali, Hayat Khan, Javed Muhammad et al.· Pharmaceutics· 0 citations
Extracellular vesicles (EVs), particularly stem cell-derived exosomes, serve as vital natural nanocarriers in regenerative medicine, immune modulation, and targeted drug delivery due to their innate ability to transport bioactive cargo across complex biological barriers. Despite this potential, the therapeutic efficacy...
The application of engineered EVs in the treatment of several pathological conditions, including cardiovascular, neurological, autoimmune, and cancer diseases, are summarized, and the major challenges in clinical translation and future perspectives for EV-based targeted therapies are discussed.
Giulia Duca, Vincenza Tinnirello, N. Ganji et al.· Molecular Biomedicine· 1 citation
Exosomes are naturally occurring nanovesicles (30–150nm) that serve as biological carriers for the targeted delivery of medicinal substances. Their membrane composition facilitates passage over physiological barriers, such as the blood-brain barrier, and offers good compatibility with bodily tissues. Using methods like...
Dhananjay A. Deore, S. Jadhav, S. Mahajan· Research Journal of Pharmace...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.